Pfizer (PFE) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

This was the stock's third consecutive day of gains.

Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a Phase 1B clinical trial titled ‘A Clinical ...

Despite recent declines, we believe Pfizer stock is a compelling buy right now, with its current price of around $23 likely reflecting existing concerns.

Regardless of which you choose, Pfizer's (NYSE: PFE) share price has declined during the period. Pfizer's dismal stock ...

PFE’s Stock Performance, Rising Estimates & Attractive Valuation. Pfizer’s stock has declined 6.9% in the past year compared with a decrease of 1.6% for the industry.

We upgraded the rating for Pfizer (PFE) stock, ... I don't think Pfizer performance improvement is adequate when comparing against SP500. Reply. Like. Robert Hutten. 28 Aug. 2024.

Pfizer Inc. (PFE), headquartered in New York, discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products. With a market cap of $149.8 billion, the company offers ...

Pfizer and S&P 500 Performance During 2007-08 Crisis. PFE stock declined from nearly $12 in September 2007 (pre-crisis peak) to $7 in March 2009 (as the markets bottomed out), implying it lost 45% ...

Pfizer (PFE-1.29%) is a stock that everyone's familiar with, ... So while bulls might be disappointed with its stock price performance, ...